US62855J1043
US62855J1043
Myriad Genetics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 824.500.000 | 837.600.000 | 1.6% |
| Cost of Revenue | 247.900.000 | 252.200.000 | 1.7% |
| Gross Profit | 576.600.000 | 585.400.000 | 1.5% |
| 644.400.000 | 673.400.000 | 4.3% | |
| Operating Income | -67.800.000 | -88.000.000 | 23.0% |
| Pretax Income | -395.100.000 | -123.500.000 | 219.9% |
| Net Income Common Stockholders | -365.900.000 | -127.300.000 | 187.4% |
| -- | -- | -- | |
| -- | -- | -- |